Millipore Sigma Vibrant Logo

341291 Fas/FasL Antagonist, Kp7-6 - Calbiochem

The Fas/FasL Antagonist, Kp7-6 controls the biological activity of Fas/FasL. This small molecule/inhibitor is primarily used for Cancer applications.

Fas/FasL Antagonist, Kp7-6 - Calbiochem: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: H-YC*DEHFC*Y-OH, Cyclic [Cys-Cys disulfide], Kp7-6

Primary Target: Fas/FasL-mediated cellular apoptotic signals
View Products on Sigmaaldrich.com
341291
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

Empirical Formula
C₄₈H₅₆N₁₀O₁₅S₂

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
341291-25MG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Kst.-Ampulle 25 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewAn exocyclic cystine-knot peptide that specifically antagonizes Fas/FasL-mediated cellular apoptotic signals (58% reduction of FasL-induced apoptosis in Jurkat cells at 1 mg/ml). Binds to FasL (Cat. Nos. PF033 and PF092) and Fas (CD95/APO-1) with comparable affinity (Kd = 11.2 & 13.2 µM, respectively), resulting in disabled receptor ensembles and altered signaling pathways. Shown to prevent Con A (Cat. No. 234567)-induced liver injury in a murine hepatitis model in vivo. Does not bind to TNF-α or TNFR.
      Catalogue Number341291
      Brand Family Calbiochem®
      SynonymsH-YC*DEHFC*Y-OH, Cyclic [Cys-Cys disulfide], Kp7-6
      References
      ReferencesCarmona, E.M., et al. 2006. J. Immunol. 177, 459.
      Hasegawa, A., et al. 2004. Proc. Natl. Acad. Sci. USA 101, 6599.
      Product Information
      ATP CompetitiveN
      DeclarationSold under license of U.S. Patent 7,288,519.
      FormWhite lyophilized powder
      FormulationSupplied as a trifluoroacetate salt.
      Hill FormulaC₄₈H₅₆N₁₀O₁₅S₂
      Chemical formulaC₄₈H₅₆N₁₀O₁₅S₂
      Hygroscopic Hygroscopic
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetFas/FasL-mediated cellular apoptotic signals
      Primary Target IC<sub>50</sub>Kd = 11.2 & 13.2 µM for FasL and Fas (CD95/APO-1), respectively
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Peptide SequenceH₂N-Tyr-Cys*-Asp-Glu-His-Phe-Cys*-Tyr-CO₂H, Cyclic [disulfide bond between Cys-Cys]
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      341291-25MG 04055977215618

      Documentation

      Fas/FasL Antagonist, Kp7-6 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Fas/FasL Antagonist, Kp7-6 - Calbiochem Analysenzertifikate

      TitelChargennummer
      341291

      Literatur

      Übersicht
      Carmona, E.M., et al. 2006. J. Immunol. 177, 459.
      Hasegawa, A., et al. 2004. Proc. Natl. Acad. Sci. USA 101, 6599.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-January-2013 JSW
      SynonymsH-YC*DEHFC*Y-OH, Cyclic [Cys-Cys disulfide], Kp7-6
      DescriptionAn exocyclic cysteine-knot peptide that specifically antagonizes Fas/FasL-mediated cellular apoptotic signals (58% reduction of FasL-induced apoptosis in Jurkat cells at 1 mg/ml). Binds to FasL (Cat. Nos. PF033 and PF092) and Fas (CD95/APO-1) with comparable affinity (Kd = 11.2 & 13.2 µM, respectively), resulting in disabled receptor ensembles and altered signaling. Shown to prevent Con A (Cat. No. 234567)-induced liver injury in a murine hepatitis model in vivo. Does not bind to TNF-α or TNFR.
      FormWhite lyophilized powder
      FormulationSupplied as a trifluoroacetate salt.
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₄₈H₅₆N₁₀O₁₅S₂
      Peptide SequenceH₂N-Tyr-Cys*-Asp-Glu-His-Phe-Cys*-Tyr-CO₂H, Cyclic [disulfide bond between Cys-Cys]
      Purity≥98% by HPLC
      SolubilityDMSO (5 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesCarmona, E.M., et al. 2006. J. Immunol. 177, 459.
      Hasegawa, A., et al. 2004. Proc. Natl. Acad. Sci. USA 101, 6599.